DaxibotulinumtoxinA for Blepharospasm

Clinical trial NCT07489430 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07489430
Sponsor: University of Pennsylvania
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Blepharospasm of Both Eyelids Blepharospasm of Left Eyelid Blepharospasm of Right Eyelid Blepharospasm, Benign Essential Blepharospasm

Start date: 2026-07-01
Primary completion: 2028-06-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.